• In the second quarter of 2026, Genpact reported higher sales of US$1,343.44 million and net income of US$145.74 million, alongside updated guidance and continued share repurchases under its long-running buyback program.
• An interesting feature of this update is how Genpact’s pivot toward AI-focused Advanced Technology Solutions is coinciding with ongoing buybacks, tightening the share count while the business mix shifts toward higher-value services.
• With Genpact reaffirming guidance and leaning into AI-driven services, we’ll now examine how this latest earnings update reshapes its investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Genpact Investment Narrative Recap

To own Genpact, you need to believe its shift from traditional BPO toward AI-heavy Advanced Technology Solutions can support earnings while client demand remains muted. The latest quarter’s higher sales, reaffirmed 2026 guidance, and continued buybacks support that narrative in the near term, but the key short term catalyst is still execution in AI services, and the biggest risk remains slower client decision making that could delay converting its pipeline into revenue.

The most relevant update here is Genpact’s new guidance for Q3 and full year 2026, which anchors expectations around at least 7% reported revenue growth, an 11.1% net income margin, and diluted EPS of US$3.51. That outlook sits alongside a multi-year buyback program that has retired about 38.7% of shares, tying the catalyst of higher value AI-led growth to a shrinking share base and making any shortfall in demand or deal conversion more visible in future results.

But while Genpact is leaning into AI rich services, investors should also be aware that if enterprise AI adoption cools after the initial experimentation phase...

Genpact's narrative projects $6.4 billion revenue and $745.2 million earnings by 2029. This requires 7.3% yearly revenue growth and about a $175.6 million earnings increase from $569.6 million today.

Uncover how Genpact's forecasts yield a $39.27 fair value, a 15% upside to its current price.

Exploring Other Perspectives

Some analysts were far more optimistic before this update, assuming revenue could reach about US$6.6 billion and earnings about US$800 million, so if you are weighing that bullish view against concerns about AI adoption slowing or partner dependency, it is worth recognizing how wide the opinions are and how this latest quarter could shift those expectations in different directions.

Explore 5 other fair value estimates on Genpact - why the stock might be worth over 3x more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Genpact research is our analysis highlighting 5 key rewards that could impact your investment decision.
• Our free Genpact research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Genpact's overall financial health at a glance.

No Opportunity In Genpact?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• Find 51 companies with promising cash flow potential yet trading below their fair value.
• The latest GPUs need a type of rare earth metal called Dysprosium and there are only 28 companies in the world exploring or producing it. Find the list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.